Quality indicators of surgery for adenocarcinoma of the esophagus and gastroesophageal junction

Recent Results in Cancer Research

Volumn 182, Issue , 2010, Pages 127-142

  Lerut, Toni ^a   Decker, Georges ^a   Coosemans, Willy ^a   De Leyn, Paul ^a   Decaluwé, Herbert ^a   Nafteux, Philippe ^a   Van Raemdonck, Dirk ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT THERAPY; ASPIRATION BIOPSY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; ENDOSCOPY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS RESECTION; GASTRECTOMY; HUMAN; LONG TERM CARE; LOWER ESOPHAGUS SPHINCTER; LYMPHADENECTOMY; MINIMALLY INVASIVE SURGERY; MULTIMODALITY CANCER THERAPY; PATIENT SELECTION; PERIOPERATIVE PERIOD; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; RISK BENEFIT ANALYSIS; ROBOTICS; STOMACH ADENOCARCINOMA; STOMACH CARCINOMA; SURGICAL APPROACH; SURGICAL TECHNIQUE; SURVIVAL TIME; TOTAL QUALITY MANAGEMENT; TREATMENT INDICATION; TREATMENT OUTCOME; ADENOCARCINOMA; ESOPHAGEAL NEOPLASMS; LYMPH NODE DISSECTION; PATHOLOGY; STOMACH NEOPLASMS;

ADENOCARCINOMA; COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; ESOPHAGOGASTRIC JUNCTION; HUMANS; LYMPH NODE EXCISION; NEOPLASM STAGING; QUALITY CONTROL; STOMACH NEOPLASMS; SURGICAL PROCEDURES, MINIMALLY INVASIVE; MINIMALLY INVASIVE SURGICAL PROCEDURES;

EID: 77956031793     PISSN: 00800015     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-540-70579-6_11     Document Type: Review

References (70)

1. Altorki N (2005) En-bloc esophagectomy. The threefield dissection. Surg Clin N Am 85:611-619
2. Ancona E, Ruol A, Santi Set al. (2001) Only pathologic complete response to neoadjuvant chemo- therapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinoma. Cancer 91:2165-2174
3. Bandstrup B (2006) Fluid therapy for the surgical patient. Best Pract Res Clin Anesthesiol 20: 265-283
4. Bedenne L, Michel P, Bouché O, Milan C, Mariette C, Conroy T, Pezet D, Roullet B, Seitz J, Herr J, Paillot B, Arveux P, Bonnetain F, Binquet C (2007) Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. J Clin Oncol 25:1160-1168
5. Birkmeyer JD, Siewers AE, Finlayson EVA, Stukel TA, Lucas FL, Batista I, Welch HG, Wennberg DE (2002) Hospital volume and surgical mortality in the United States. N Engl J Med 346:1128-1137
6. Birkmeyer JD, Sun Y, Wong SL, Stukel TA (2007) Hospital volume and late survival after cancer surgery. Ann Surg 245:777-783
7. Blumenthal D (1996) Measuring quality of care. New Engl J Med 335:966-970
8. Bandstrup B, Tonnesen H, Beier-Holgersen R, Hjortso E, Ording H, Lindorff-Larsen Ket al. (2003) Effects of intravenous fluid restriction on postoperative complications: comparison of two perioperative fluid regimens: a randomized assessor-blinded multicenter trial. Ann Surg 238:641-648
9. Cerfolio RJ, Bryant AS, Bass CS, Alexander JR, Bartolucci AA (2004) Fast tracking after Ivor Lewis esophagogastrectomy. Chest 126:1187-1194
10. Chang AC, Ji H, Birkmeyer NJ, Orringer MB, Birkmeyer JD (2008) Outcomes after transhiatal and transthoracic esophagectomy for cancer. Ann Thorac Surg 85:424-429
11. Chemaly M, Scalone O, Durivage G, Napoleon B, Pujol B, Lefort C, Hervieux V, Scoazec JY, Souquet JC, Ponchon T (2008) Miniprobe EUS in the pretherapeutic assessment of early esophageal neoplasia. Endoscopy 40:2-6
12. Cushieri A, Shimi S, Banting S (1992) Endoscopic oesophagectomy through a right thoracoscopic approach. J R Coll Surg Edinb 37:7-11
13. De Manzoni G, Pedrazzani C, di Leo Aet al. (1999) Experience of endoscopic ultrasound with a 20-Mhz ultrasound thin probe. Eur J Surg Oncol 25:595-598
14. Decker G, Coosemans W, De Leyn P, Decaluwé H, Nafteux P, Van Raemdonck D, Lerut T (2009) Minimally invasive esophagectomy for cancer. Eur J Cardiothorac Surg 35:13-21
15. Driessen A, Van Raemdonck D, De Leyn Pet al. (2003) Are carcinomas of the cardia oesophageal or gastric adenocarcinomas? Eur J Cancer 39:2487-2494
16. Driessen A, Nafteux P, Lerut Tet al. (2004) Identical cytokeratin expression pattern CK7+/CK20- in esophageal and cardiac cancer: etiopathological and clinical implications. Mod Pathol 17: 49-55
17. Edge S.B, Byrd D.R., Compton C, Fritz A.G., Greene F.L., Trotti A (2009) AJCC Cancer Staging Manual 7th Edition, Springer, New York
18. Egger M, Ebrahim S, Smith GD (2002) Where now for meta-analysis? Int J Epidemiol 31:1-5
19. Enzinger PC, Mayer RJ (2003) Esophageal cancer. N Engl J Med 349:2241-2252
20. Fiorica F, Di Bona D, Schepsis Fet al. (2004) Preoperative chemoradiotherapy for esophageal cancer: a systematic review and meta-analysis. Gut 53:925-930
21. Fumagalli U (1996) Resective surgery for cancer of thoracic esophagus. Results of a consensus conference of the International Society for Diseases of the Esophagus. Dis Esophagus 9:30-38
22. Gebski V, Burmeister B, Smithers B, Foo K, Zalcberg J, Simes J, Australasian Gastro-Intestinal Trials Group (2007) Survival benefits for neoadjuvant chemoradiotherapy or chemo-therapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol 8:226-234
23. Geh JI, Bond SJ, Bentzen SMet al. (2006) Systematic overview of preoperative (neoadjuvant) chemoradiotherapy trials in oesophageal cancer: evidence of a radiation and chemotherapy dose response. Radiother Oncol 78:236-244
24. Greene FL, Page DL, Fleming ID, Fritz AG, Balck CM, Haller DG, Morrow M (2002) AJCC cancer staging handbook. TNM classification of malignant tumors, 6th edn. Springer, New York
25. Greer S, Goodney P, Sutton J, Birkmeyer J (2005) Neoadjuvant chemoradiotherapy for esophageal carcinoma: a meta-analysis. Surgery 137: 172-177
26. Guideline for the esophageal and gastric cancer: scientific support of the college of Oncology. www. kce.fgov.be. 21 Mar 2008
27. Holte K, Kehlet H (2006) Fluid therapy and surgical outcomes in elective surgery: a need for reassessment in fast-track surgery. J Am Coll Surg 202:971-989
28. Hulscher JBF, Tijssen JGP, Obertop H, van Lanschot JJB (2001) Transthoracic versus transhiatal resection for carcinoma of the esophagus: a meta-analysis. Ann Thor Surg 72:306-313
29. Jadad AR, Moore RA, Carroll Det al. (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17:1-12
30. Joshi GP (2005) Intraoperative fluid restriction improves outcome after major elective gastrointestinal surgery. Anesth Analg 101:601-605
31. Kelly S, Harris KM, Berry Eet al. (2001) A systematic review of the staging performance of endoscopic ultrasound in gastro-oesophageal carcinoma. Gut 49:534-539
32. Kelsen D, Ginsberg R, Pajak T, Sheahan D, Gunderson L, Mortimer J, Estes N, Haller D, Ajani J, Kocha W, Minsky B, Roth J (1998) Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med 339:1979-1984
33. Kutup A, Link BC, Schurr PG, Strate T, Kaifi JT, Bubenheim M, Seewald S, Yekebas EF, Soehendra N, Izbicki JR (2007) Quality control of endoscopic ultrasound in preoperative staging of esophageal cancer. Endoscopy 39:715-719
34. Lagarde SM, ten Kate FJet al. (2006) Prognostic factors in adenocarcinoma of the esophagus or gastroesophageal junction. J Clin Oncol 24:4347-4355
35. Law S (2006) Minimally invasive techniques for oesophageal cancer surgery. Best Pract Res Clin Gastroent 20:925-940
36. Lerut T, Coosemans W, De Leyn P, Van Raemdonck D, Nafteux P, Moons J (2001) Optimizing treatment of carcinoma of the esophagus and gastroesophageal junction. Surg Clin North Am 10:863-884
37. Lerut T, Coosemans W, Decker G, De Leyn P, Ectors N, Fieuws S, Moons J, Nafteux P, Van Raemdonck D; for the Leuven Collaborative Workgroup for Esophageal Carcinoma (2003) Extracapsular lymph node involvement is a negative prognostic factor in T3 adenocarcinoma of the distal esophagus and gastroesophageal junction. J Thor Cardiovasc Surg 126:1121-1128
38. Lerut T, Nafteux P, Moons J, Coosemans W, Decker G, De Leyn P, Van Raemdonck D, Ectors N (2004) Three-field lymphadenectomy for carcinoma of the esophagus and gastroesophageal junction in 174 R0 resections: impact on staging, disease-free survival and outcome: a plea for adaptation of TNM classification in upper-half esophageal carcinoma. Ann Surg 240:962-974
39. Lerut T, Moons J, Coosemans W, Decaluwé H, Decker G, De Leyn P, Nafteux P, VanRaemdonck D (2008) Multidisciplinary treatment of advanced cancer of the esophagus and gastroesophageal junction: a European center's approach. Surg Oncol Clin N Am 17:485-502
40. Lightdale CJ, Kulkarni KG (2005) Role of endoscopic ultrasonography in the staging and follow-up of esophageal cancer. J Clin Oncol 23:4483-4489
41. Low DE (2007) Evolution in perioperative management of patients undergoing oesophagectomy. Br J of Surg 94:655-656
42. Luketich JD, Alvelo-Rivera M, Buenaventura PO, Christie NA, McCaughan JS, Litle VR, Schauer PR, Close JM, Fernando HC (2003) Minimally invasive esophagectomy. Outcomes in 222 patients. Ann Surg 238:486-495
43. Malthaner R, Fenlon D (2003) Preoperative chemotherapy for resectable esophageal cancer. Cochrane Database Syst Rev (4):CD001556
44. Malthaner R, Wong R, Rumble R, Zuraw L (2004) Gastrointestinal Disease Group of Cancer Care Ontario's Program in evidence-based care. Neoadjuvant or adjuvant therapy for resectable esophageal cancer: a clinical practice guideline. BMC Cancer 4:67
45. May A, Günter E, Roth F, Gossner L, Stolte M, Vieth M, Ell C (2004) Accuracy of staging in early oesophageal cancer using high resolution endoscopy and high resolution endosonography: a comparative, prospective and blinded trial. Gut 53:634-640
46. Medical Research Council Oesophageal Cancer Working Group (2002) Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet 359:1727-1734
47. Meyers BF, Downey RJ, Decker PA, Keenan RJ, Siegel BA, Cerfolio RJ, Landreneau RJ, Reed CE, Balfe DM, Dehdashti F, Ballman KV, Rusch VW, Putnam JB (2007) The utility of positron emission tomography in staging of potentially operable carcinoma of the thoracic esophagus: results of the American College of Surgeons Oncology Group Z0060 trial. J Thorac Cardiovasc Surg 133:738-745
48. NCCN. NCCN (2002) clinical practice guidelines in oncology: esophageal cancer. Version 2009. www.nccn.org
49. Nishimaki T (2006) An appropriate esophagectomy for esophageal cancer: a lack of evidence and a growing disparity between Western and Eastern standards. Ann Thorac Cardiovasc Surg 12: 231-233
50. Omloo JM, Lagarde SM, Hulscher JB, Reitsma JB, Fockens P, van Dekken H, Ten Kate FJ, Obertop H, Tilanus HW, van Lanschot JJ (2007) Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial. Ann Surg 246:992-1000
51. Pera M, Manterola Cet al. (2005) Epidemiology of esophageal adenocarcinoma. J Surg Oncol 92: 151-159
52. Peters FP, Brakenhoff KPM, Curvers WL, Rosmolen WD, Fockens P, ten Kate FJW, Krishnadath KK, Bergman JJ (2008) Histologic evaluation of resection specimens obtained at 293 endoscopic resections in Barrett's esophagus. Gastroint Endosc 67:604-609
53. Peyre C, Hagen J, DeMeester SR, Altorki NK, Ancona E, Griffin SM, Hölscher A, Lerut T, Law S, Rice T, Ruol A, van Lanschot JJB, Wong J, De Meester TR (2008) The number of lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resection. Ann Surg 248:549-555
54. Rindani R, Martin CJ, Cox MR (1999) Transhiatal versus Ivor-Lewis oesophagectomy: is there a difference? Aust NZ J Surg 69:187-194
55. Siewert JR, Stein HJ (1998) Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg 85:1457-1459
56. Smithers BM, Gotley DC, Martin I, Thomas JM (2007) Comparison of the outcomes between open and minimally invasive esophagectomy. Ann Surg 245:232-240
57. Sobin LH, Wittekind C (eds) (2002) International Union against cancer (IUICC) TNM classification of malignant tumours, 6th edn. Wiley-Liss, New-York
58. Spechler SJ, Dixon MF, Genta R, Hainaut P, Lambert R, Siewert R (2000) Adenocarcinoma of the esophago-gastric junction. In: Hamilton SR, Aaltonen LA (eds) World Health Organization classification of tumours, vol 2. Pathology and genetics of tumours of the digestive system. IARC, Lyon, France, pp 31-36
59. Stahl M, Stuschke M, Lehmann N, Meyer H, Walz M, Seeber S, Klump B, Budach W, Teichmann R, Schmitt M, Schmitt G, Franke C, Wilke H (2005) Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. JCO 23:2310
60. Urschel J, Vasan H (2003) A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer. Am J Surg 185:538-543
61. van Lanschot JJ, Hulscher JB, Buskens CJ, Tilanus HW, ten Kate FJ, Obertop H (2001) Hospital volume and hospital mortality for esophagectomy. Cancer 91:1574-1578
62. Van Raemdonck D, Van Cutsem E, Menten J, Ectors N, Coosemans W, De Leyn P, Lerut T (1997) Induction therapy for clinical T4 oesophageal carcinoma; a plea for continued surgical exploration. Eur J Cardiothorac Surg 11: 828-837
63. Van Vliet EP, Eijkemans MJet al. (2006) Staging of esophageal carcinoma in a low-volume EUS center compared with results from high-volume centers. Gastrointest Endosc 63:938-947
64. Van Vliet EP, Hermans JJ, De Wever W, Eijkemans MJ, Steyerberg EW, Faasse C, van Helmond EP, de Leeuw AM, Sikkenk AC, de Vries AR, de Vries EH, Kuipers EJ, Siersema PD (2008) Radiologist experience and CT examination quality determine metastasis detection in patients with esophageal or gastric cardia cancer. Eur Radiol 18:2475-2484
65. Vrouenraets BC, van Lanschot JJB (2006) Extent of surgical resection for esophageal and gastroesophageal junction adenocarcinomas. Surg Oncol Clin N Am 15:781-791
66. Walsh T, Noonan N, Hollywood Det al. (1996) Comparison of multimodal therapy and surgery for oesophageal adenocarcinoma. N Engl J Med 335:462-467
67. Wittekind C, Green FL, Henson DE, Hutter RVP, Sobin LH (2003) TNM supplement: a commentary on uniform use, 3rd edn. Wiley-Liss, New-York
68. Yamamoto S, Kawahara K, Maekawa T, Shiraishi T, Shirakusa T (2005) Minimally invasive esophagectomy for stage I and II esopageal cancer. Ann Thor Surg 80:2070-2075
69. Zher KJ, Dawson PB, Yang SC, Heitmiller RF (1998) Standardized clinical care pathways for major thoracic cases reduces hospital costs. Ann Thorac Surg 66:914-919
70. Zuccaro G, Rice TW, Vargo JJet al. (2005) Endoscopic ultrasound errors in esophageal cancer. Am J Gastroenterol 100:1216 (The authors describe the difficulties in discriminating between pT1b-T2 and pT3-T4 withpT3-T4 with misclassification by EUS of disease extent in 15%)